[Free Domestic Webinar] Introduction to the Industry Standard Bio-Reactor Ambr250 High Throughput Generation 2 Optimized for Process Characterization Analysis

Industry-standard high-throughput bioreactor system optimized for process characteristic analysis.

The Ambr 250 High Throughput Generation 2 is a multi-parallel bioreactor system that accelerates process development and characterization analysis schedules to achieve cost reduction. Its fully continuous gas supply system realizes similarity with large-scale bioreactors and optimizes the scale-down model. Through the integration of analysis options such as the capacitance-based BioPAT Viamass, it supports extensive feedback control.

• others
• Culture Equipment
• Bioreactor

A new bioreactor system for parallel operation of microbial culture or cell culture!

The "Ambr250" is a new bioreactor system for parallel operations of microbial or cell cultures using single-use bioreactors with a capacity of 100 to 250 mL, controlled by an automated liquid handling platform. This system was developed in collaboration with two major pharmaceutical companies, based on the micro bioreactor technology held by Sartorius Stedim's TAP division. It supports the necessary culture conditions required for microbial cultivation and mammalian cell culture, which demand advanced technology, as well as applications that require larger sample collections. 【Features】 ■ Individual control of all process parameters ■ Improved operating environment ■ Efficient and rapid miniaturization system ■ Equipped for scalability to benchtop bioreactors ■ Capable of screening a wide range of culture conditions and strains or cell lines *For more details, please refer to the PDF document or feel free to contact us.

• Other physicochemical equipment

A fully automated bioreactor system for the development of high-density cell culture processes!

The "Ambr250 Perfusion" is a fully automated multi-parallel bioreactor system that uses single-use culture vessels of 100-250 mL to accelerate the development of scalable perfusion processes. This system allows for the simultaneous execution of up to 24 different perfusion cultures while returning cells to the culture vessel using hollow fibers, which are commonly reported specifications. This system transforms the perfusion processes that could not be achieved with multi-parallel or small-scale setups, reducing experimental costs with small volumes and accelerating the optimization of high-density cell culture processes. 【Features】 ■ Increased productivity / Reduced experimental costs ■ Simultaneous parallel fed-batch and perfusion cultures are also possible ■ Exceptional scalability ■ Sampling and reagent addition are performed by a fully automated liquid handler, reducing daily working hours *For more details, please refer to the PDF document or feel free to contact us.

• Other physicochemical equipment

A single-use benchtop bioreactor with simple operation aimed at improving productivity.

The industry-standard multi-channel, compact fully automated bioreactor, Ambr250 in a benchtop configuration, has arrived with new features and applications for regenerative medicine. It allows for independent cultivation with highly controlled single-use containers with operating capacities of 100-250 mL, arranged in a maximum of 8 channels. There are three types of containers, each specialized for cells, microorganisms, and regenerative medicine, with a refined design that contributes to process development and optimization. Since the containers are single-use and sterilized, they enable fast turnover, accelerating customers' research and development activities. Because it is geometrically identical to bioreactors used for production scale in pharmaceuticals and regenerative medicine products, it is possible to quickly transition and implement optimized cultivation and production conditions.

• Other physicochemical equipment

Bioreactor system for cell line development and process optimization.

The Ambr1515 Generation 2 is a high-throughput "automated micro-scale bioreactor system" that reproduces the performance of laboratory-scale bioreactors. The system consists of single-use vessels, an automated workstation, and enhanced convenience software. It is designed to be installed in a standard biosafety cabinet for aseptic operations, allowing for parallel monitoring and control of 24 or 48 micro-bioreactor cultures. As the manufacturing processes for biopharmaceuticals become more complex and the density of cultures increases, scientists around the world are facing an unprecedented challenge in developing "clone, medium, and process" that meet new demands. The Ambr15 Generation 2 system enhances equipment performance that influences the success of cultures, improves flexibility, and incorporates new features that reflect user feedback. It helps address the aforementioned challenges and supports the acceleration of research by scientists.

• others

Enhancing equipment performance that influences the success of cultivation! We have achieved improved flexibility.

The "Ambr15 Generation2" is a high-throughput automated micro-scale bioreactor system that replicates the performance of laboratory-scale bioreactors. The system consists of single-use vessels, an automated workstation, and user-friendly software. It is designed to be installed in standard biosafety cabinets for aseptic operations, allowing for parallel monitoring and control of 24 or 48 micro-bioreactor cultures. 【Features】 ■ Reduces operator time and increases work efficiency ■ Facilitates the process of determining the best clone ■ Enables faster and more accurate operations ■ Capable of complex liquid mixing and addition for multifactorial experimental designs (DoE) ■ Used in research facilities worldwide *For more details, please refer to the PDF document or feel free to contact us.

• Other physicochemical equipment

Introducing options and accessories that can be added to the Ambr 15 Generation 2.

You can find the following information in this catalog: ▪ System specifications ▪ Compatible at-line analyzers ▪ Expandable options ▪ Accessories ▪ Ambr 15 microbioreactor (culture vessel) ▪ Plates and chips

• Other physicochemical equipment
• others

CHO Cell Culture Optimization: A DOE Approach in the Ambr 15

Selecting the appropriate combination of culture media and feeds for cells, and further optimizing process parameters, is a complex and time-consuming process. Sartorius's extensive portfolio of media and micro-bioreactors that allow for parallel cultivation support optimal and scalable process development for cells. This application note introduces the process optimization of CHO cell culture using Sartorius media, Ambr15, and the experimental design software MODDE.

• Software (middle, driver, security, etc.)
• Culture medium
• Culture Equipment

Nitto Kohki will hold the "2025 Attack Fair in Meiko" for two days from July 23 (Wednesday) to July 24 (Thursday), 2025, at the "Kowa Seminar Plaza 2F Training Room NO.12 (inside Kowa Sports Land)." The Attack Fair is an exhibition where you can actually "see, touch, and operate" Nitto Kohki's products. Additionally, there will be wonderful souvenirs for attendees and many fun activities planned. We look forward to welcoming everyone!

[Lecturers] Daisuke Tateno, Partner, Arthur D. Little Japan K.K. Akihiro Nagayama, Principal [Key Lecture Content] Drones, AI, software, satellites, and electronic warfare are fundamentally changing the way wars are fought, and the defense industry is currently transitioning from a heavy and traditional model to one centered around AI, software, data, and unmanned systems. In the United States, emerging companies like Palantir and Anduril, which are software-driven, are challenging existing defense firms. In Japan, structural changes are beginning with the Defense Capability Development Plan, the Defense Industry Base Strengthening Act, and the entry of startups. This seminar will discuss the changes in the global security environment and industrial structure, the strategies of advanced players both domestically and internationally, and the areas where Japanese companies can succeed, including dual-use, collaboration with software companies, M&A and alliances, and talent strategies. We will consider how to view change not as a threat but as a growth opportunity, and how to construct a new Japanese defense industry from a management perspective.

[Speaker] Kazuki Miyamoto, Representative/Analyst, VentureClef, USA [Key Lecture Content] The frontier model in the United States is evolving at an unexpected speed. AI agents based on the frontier model have completely transformed business forms in companies. Chinese companies are developing large-scale open source projects, and their performance is approaching that of the U.S. model. Meanwhile, U.S. companies have begun developing open source, leading to a direct confrontation between the U.S. and China. The seminar will examine the frontier models of both countries and explain the latest technologies and important trends. It will organize points on how Japanese companies should perceive the U.S.-China AI development competition from technological and business perspectives. It will also consider strategies for companies to succeed in the AI era, including the differentiation between the U.S. and Chinese models, as well as the advantages and challenges of open source versus closed source. [Lecture Items] <1> Frontier Model (USA) <2> Frontier Model (China) <3> Technology Trends and AI Strategies for Japanese Companies <4> Q&A

[Speaker] Chief Expert Ji Hui, Future Creation Center, Nomura Research Institute, Inc. [Key Lecture Content] *We plan to update with the latest information based on field research as necessary.* At the World Artificial Intelligence Conference held in Shanghai in July 2026, Huawei unveiled its next-generation computing infrastructure products based on its proprietary AI chips, attracting significant attention. Amid ongoing U.S. export restrictions on advanced semiconductors, Huawei demonstrated its approach to overcoming the performance limits of standalone chips through "systems engineering," showcasing its commitment to leading the development of an autonomous AI ecosystem in China, encompassing computing infrastructure, cloud, OS, and AI models. Based on the latest field research results, this lecture will explain the latest trends in Huawei's AI strategy (computing infrastructure, AI models: AI social implementation, AI ecosystem, etc.) in the context of the overall landscape of China's AI industry. [Lecture Topics] 1. Current State of China's AI Industry 2. Progress in Domestic Production of Infrastructure 3. Huawei's Full-Stack AI Ecosystem 4. Future Prospects 5. Q&A

[Key Lecture Content] 1. Overview of the Law Amending Part of the Act on the Protection of Personal Information (Amendment of 2023) Kento Kido, Deputy Director, Personal Information Protection Commission 1. Background leading to the enactment of the amended law 2. Amendment Content [1] (Promotion of Proper Data Utilization) 3. Amendment Content [2] (Regulations Responding Appropriately to Risks) 4. Amendment Content [3] (Prevention of Improper Use, etc.) 5. Amendment Content [4] (Regulations to Ensure the Effectiveness of Compliance) 6. Towards the Implementation of the Amended Law (Status of Consideration for Ordinances, Regulations, Guidelines, etc.) 7. Q&A / Business Card Exchange 2. Key Points for Practical Response to the Implementation of the Amended Law Jun Okada, Partner Attorney, Mori Hamada & Matsumoto Law Firm 1. Overall Perspective on Practical Response Based on the Amended Law 2. Specific Discussion [1]: Statistical Exceptions and AI 3. Specific Discussion [2]: Handling of Children's Personal Information, etc. 4. Specific Discussion [3]: Administrative Fines 5. Specific Discussion [4]: Other Individual Issues 6. Timeline and To-Do List for Full Implementation 7. Q&A / Business Card Exchange